PANAPHIX
Live / Registered — Registered (as of 17 Oct 2023)
What this means for you
Registered since 17 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97592485
- Registration number
- 7195224
- Mark type
- Stylized text
- Filed
- 15 Sept 2022
- Published for opposition
- 01 Aug 2023
- Registered
- 17 Oct 2023
- Attorney of record
- Kwang Yup Chae
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Chemotherapy medicines; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis
Owner
- Komipharm International Co., Ltd., Gyeonggi-do, KR
- Komipharm International Co., Ltd., Gyeonggi-do, KR
- Komipharm International Co., Ltd., Gyeonggi-do, KR
Prosecution history
- 17 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Aug 2023 — PUBLISHED FOR OPPOSITION
- 12 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2023 — EXAMINER'S AMENDMENT ENTERED
- 27 Jun 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Jun 2023 — EXAMINERS AMENDMENT E-MAILED
- 27 Jun 2023 — EXAMINERS AMENDMENT -WRITTEN
- 27 Jun 2023 — ASSIGNED TO EXAMINER
- 29 Sept 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Sept 2022 — NEW APPLICATION ENTERED